URMC Related Haplo-identical Donor BMT
Public ClinicalTrials.gov record NCT02660281. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Haploidentical Donor Hematopoietic Stem Cell Transplantation
Study identification
- NCT ID
- NCT02660281
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- University of Rochester
- Other
- Enrollment
- 74 participants
Conditions and interventions
Conditions
Interventions
- Busulfan Drug
- Fludarabine Drug
- Melphalan Drug
- Post-Stem Cell Infusion Cyclophosphamide Drug
- Post-Stem Cell Infusion Mesna Drug
- Pre-Stem Cell Infusion Cyclophosphamide Drug
- Pre-Stem Cell Infusion Mesna Drug
- Stem Cell Infusion Procedure
- Thiotepa Drug
- Total Body Irradiation 1200 cGy Radiation
Drug · Procedure · Radiation
Eligibility (public fields only)
- Age range
- 6 Months to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2015
- Primary completion
- Oct 27, 2019
- Completion
- Jan 6, 2021
- Last update posted
- Nov 2, 2021
2015 – 2021
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Wilmot Cancer Institute | Rochester | New York | 14642 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02660281, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 2, 2021 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02660281 live on ClinicalTrials.gov.